M

Mega Lifesciences PCL
SET:MEGA

Watchlist Manager
Mega Lifesciences PCL
SET:MEGA
Watchlist
Price: 35.25 THB -0.7% Market Closed
Market Cap: 30.7B THB
Have any thoughts about
Mega Lifesciences PCL?
Write Note

Intrinsic Value

The intrinsic value of one MEGA stock under the Base Case scenario is 53.62 THB. Compared to the current market price of 35.25 THB, Mega Lifesciences PCL is Undervalued by 34%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MEGA Intrinsic Value
53.62 THB
Undervaluation 34%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation Backtest
Mega Lifesciences PCL

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MEGA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MEGA?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Mega Lifesciences PCL

Provide an overview of the primary business activities
of Mega Lifesciences PCL.

What unique competitive advantages
does Mega Lifesciences PCL hold over its rivals?

What risks and challenges
does Mega Lifesciences PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mega Lifesciences PCL.

Provide P/S
for Mega Lifesciences PCL.

Provide P/E
for Mega Lifesciences PCL.

Provide P/OCF
for Mega Lifesciences PCL.

Provide P/FCFE
for Mega Lifesciences PCL.

Provide P/B
for Mega Lifesciences PCL.

Provide EV/S
for Mega Lifesciences PCL.

Provide EV/GP
for Mega Lifesciences PCL.

Provide EV/EBITDA
for Mega Lifesciences PCL.

Provide EV/EBIT
for Mega Lifesciences PCL.

Provide EV/OCF
for Mega Lifesciences PCL.

Provide EV/FCFF
for Mega Lifesciences PCL.

Provide EV/IC
for Mega Lifesciences PCL.

Show me price targets
for Mega Lifesciences PCL made by professional analysts.

What are the Revenue projections
for Mega Lifesciences PCL?

How accurate were the past Revenue estimates
for Mega Lifesciences PCL?

What are the Net Income projections
for Mega Lifesciences PCL?

How accurate were the past Net Income estimates
for Mega Lifesciences PCL?

What are the EPS projections
for Mega Lifesciences PCL?

How accurate were the past EPS estimates
for Mega Lifesciences PCL?

What are the EBIT projections
for Mega Lifesciences PCL?

How accurate were the past EBIT estimates
for Mega Lifesciences PCL?

Compare the revenue forecasts
for Mega Lifesciences PCL with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Mega Lifesciences PCL and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mega Lifesciences PCL against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mega Lifesciences PCL compared to its peers.

Compare the P/E ratios
of Mega Lifesciences PCL against its peers.

Discuss the investment returns and shareholder value creation
comparing Mega Lifesciences PCL with its peers.

Analyze the financial leverage
of Mega Lifesciences PCL compared to its main competitors.

Show all profitability ratios
for Mega Lifesciences PCL.

Provide ROE
for Mega Lifesciences PCL.

Provide ROA
for Mega Lifesciences PCL.

Provide ROIC
for Mega Lifesciences PCL.

Provide ROCE
for Mega Lifesciences PCL.

Provide Gross Margin
for Mega Lifesciences PCL.

Provide Operating Margin
for Mega Lifesciences PCL.

Provide Net Margin
for Mega Lifesciences PCL.

Provide FCF Margin
for Mega Lifesciences PCL.

Show all solvency ratios
for Mega Lifesciences PCL.

Provide D/E Ratio
for Mega Lifesciences PCL.

Provide D/A Ratio
for Mega Lifesciences PCL.

Provide Interest Coverage Ratio
for Mega Lifesciences PCL.

Provide Altman Z-Score Ratio
for Mega Lifesciences PCL.

Provide Quick Ratio
for Mega Lifesciences PCL.

Provide Current Ratio
for Mega Lifesciences PCL.

Provide Cash Ratio
for Mega Lifesciences PCL.

What is the historical Revenue growth
over the last 5 years for Mega Lifesciences PCL?

What is the historical Net Income growth
over the last 5 years for Mega Lifesciences PCL?

What is the current Free Cash Flow
of Mega Lifesciences PCL?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mega Lifesciences PCL.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mega Lifesciences PCL

Current Assets 9.6B
Cash & Short-Term Investments 2.9B
Receivables 3.3B
Other Current Assets 3.4B
Non-Current Assets 4B
Long-Term Investments 71.8m
PP&E 2.2B
Intangibles 1.3B
Other Non-Current Assets 352.8m
Current Liabilities 3.9B
Accounts Payable 1.8B
Accrued Liabilities 873.9m
Short-Term Debt 168.7m
Other Current Liabilities 1B
Non-Current Liabilities 409.2m
Long-Term Debt 144.6m
Other Non-Current Liabilities 264.5m
Efficiency

Earnings Waterfall
Mega Lifesciences PCL

Revenue
15.8B THB
Cost of Revenue
-8.1B THB
Gross Profit
7.7B THB
Operating Expenses
-4.4B THB
Operating Income
3.3B THB
Other Expenses
-1.4B THB
Net Income
1.8B THB

Free Cash Flow Analysis
Mega Lifesciences PCL

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MEGA Profitability Score
Profitability Due Diligence

Mega Lifesciences PCL's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROIC
Positive 3-Year Average ROE
Positive Free Cash Flow
64/100
Profitability
Score

Mega Lifesciences PCL's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

MEGA Solvency Score
Solvency Due Diligence

Mega Lifesciences PCL's solvency score is 94/100. The higher the solvency score, the more solvent the company is.

94/100
Solvency
Score

Mega Lifesciences PCL's solvency score is 94/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MEGA Price Targets Summary
Mega Lifesciences PCL

Wall Street analysts forecast MEGA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEGA is 42.16 THB with a low forecast of 25.25 THB and a high forecast of 58.8 THB.

Lowest
Price Target
25.25 THB
28% Downside
Average
Price Target
42.16 THB
20% Upside
Highest
Price Target
58.8 THB
67% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MEGA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MEGA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Mega Lifesciences PCL

Country

Thailand

Industry

Pharmaceuticals

Market Cap

30.7B THB

Dividend Yield

1.56%

Description

Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2013-11-19. The firm's products include complimentary medicines, over-the-counter (OTC) medicines and prescription medicines to both domestic and international markets. The company distributes products under Maxxcare brand covering prescription pharmaceutical products, OTC drugs and other consumer products. The firm also offers nutritional products, prescription pharmaceutical products and OTC drugs under Mega We Care brand. In addition, the Company operates as an original equipment manufacturer (OEM) for various products including health supplements, pharmaceutical, herbal products, vitamins and minerals, among others.

Contact

BANGKOK METROPOLIS
Bangkok
No. 120, Moo 11, Ample Tower, 9th-10th Floor, Bangna-Trad Road, Bangna
+6627694222
www.megawecare.com

IPO

2013-11-19

Employees

6 021

Officers

CEO, Chief Coach & Executive Director
Mr. Vivek Dhawan
CFO & Executive Director
Mr. Thomas Abraham
Chief Risk & Compliance Officer
Mr. Deepak Panjwani
President of International
Mr. Paramjit Singh Sawhney
President of Myanmar
Mr. Girish Wadhwa
Deputy Chief Financial Officer
Mr. Manoj Gurbuxani
Show More
President of Mega We Care Thailand
Ms. Duangnapa Tongsiri
Corporate Secretary
Ms. Sujintana Boonworapat
Show Less

See Also

Discover More
What is the Intrinsic Value of one MEGA stock?

The intrinsic value of one MEGA stock under the Base Case scenario is 53.62 THB.

Is MEGA stock undervalued or overvalued?

Compared to the current market price of 35.25 THB, Mega Lifesciences PCL is Undervalued by 34%.

Back to Top